A Metabolomic Strategy to Screen the Prototype Components and Metabolites of <i>Shuang-Huang-Lian Injection</i> in Human Serum by Ultra Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry

<table>UPLC-Q-TOF/MS BPI chromatograms of human serum samples (a) before <i>SHLI</i> administration in positive ion mode, (b) after <i>SHLI</i> administration in positive ion mode, (c) before <i>SHLI</i> administration in negative ion mode, and (d) after <i>SHLI</i> administration in negative ion mode.</table>

Journal of Analytical Methods in Chemistry

fig2

Figure 2

Figure 2: A Metabolomic Strategy to Screen the Prototype Components and Metabolites of <i>Shuang-Huang-Lian Injection</i> in Human Serum by Ultra Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry 

Figure 2 | A Metabolomic Strategy to Screen the Prototype Components and Metabolites of Shuang-Huang-Lian Injection in Human Serum by Ultra Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry 